miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma — M. Papadimitriou (2023) | RDL Network
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma
Article 2023 en
Authors
MP
M. Papadimitriou
KS
Konstantinos Soureas
ΑΠ
Αριστέα-Μαρία Παπανώτα
Abstract
1 min read
Our study identified miR-25 overexpression as a powerful independent predictor of poor treatment outcome and post-treatment progression, aiding towards modern non-invasive disease prognosis and personalized treatment decisions.
Konstantinos Soureas, Panagiotis Malandrakis, M. Papadimitriou, Christos Minopoulos, Ioannis Ntanasis-Stathopoulos, Christine‐Ivy Liacos, Maria Gavriatopoulou, Efstathios Kastritis, Meletios A Dimopoulos, Andreas Scorilas, Margaritis Avgeris, Evangelos Terpos
Konstantinos Soureas, Christos Minopoulos, M. Papadimitriou, Panagiotis Malandrakis, Panagiotis Adamopoulos, Ioannis Ntanasis‐Stathopoulos, Αριστέα-Μαρία Παπανώτα, Maria Gavriatopoulou, Diamantis C. Sideris, Efstathios Kastritis, Meletios A Dimopoulos, Andreas Scorilas, Evangelos Terpos, Margaritis Avgeris
Konstantinos Soureas, M. Papadimitriou, Panagiotis Malandrakis, Αριστέα-Μαρία Παπανώτα, Panagiotis G. Adamopoulos, Ioannis Ntanasis‐Stathopoulos, Christine‐Ivy Liacos, Maria Gavriatopoulou, Diamantis C. Sideris, Efstathios Kastritis, Meletios A Dimopoulos, Andreas Scorilas, Evangelos Terpos, Margaritis Avgeris
Tobias Paul Seraphin, Agavni Mesropian, Laura Žigutytė, James Brooks, Ezequiel Mauro, Albert Gris‐Oliver, Roser Pinyol, Carla Montironi, Ugne Balaseviciute, Marta Piqué‐Gili, Júlia Huguet‐Pradell, Marko van Treeck, Michael Kallenbach, Anne T. Schneider, Christoph Roderburg, Jakob Nikolas Kather, Tom Luedde, Josep M. Llovet
Discussion(0)
No comments yet. Be the first to comment.